Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical implications of lamivudine resistance by HBV.

Lancet (London, England) - 4 Jan 1997

Schalm S W

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Microbial
Share to Hepatitis B
Share to Hepatitis B virus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunocompetence

Share to Lamivudine

Share to Liver Failure

Share to Liver Transplantation

Source

Identifiers

PMID: 8988109
DOI: 10.1016/S0140-6736(05)62154-X

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical implications of lamivudine resistance by HBV.PMID 8988109Read ↗

Hepatitis B virus subtypes and lamivudine resistance.Semantic proximity Read ↗

Hepatitis B viral genotypes and lamivudine resistance.Semantic proximity Read ↗

HBV replication inhibitorsSemantic proximity Read ↗

Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection.Semantic proximity Read ↗

[Lamivudine treatment for hepatitis B].Semantic proximity Read ↗

[Lamivudine therapy for chronic hepatitis B].Semantic proximity Read ↗

Multidrug resistance after lamivudine therapy for chronic hepatitis B.Semantic proximity Read ↗

The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutationSemantic proximity Read ↗

[The influence of HBV genotypes on the therapeutic effects of lamivudine in chronic hepatitis B patients].Semantic proximity Read ↗

Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV.Semantic proximity Read ↗

Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.Semantic proximity Read ↗

HBV mutations associated with lamivudine therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.